Octapharma to build $1.5 billion state-of-the-art critical care manufacturing facility in Rock Hill, SC
New 50-acre campus will be one of the largest private biomedical investments in state's history, bringing 1,500 jobs to South Carolina Manufacturing facility will establish domestic production of Octapharma's plasma-based therapies and products of national security concern, reducing...
New 50-acre campus will be one of the largest private biomedical investments in state's history, bringing 1,500 jobs to South Carolina Manufacturing facility will establish domestic production of Octapharma's plasma-based therapies and products of national security concern, reducing...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.